Israel Englander’s Nautilus Biotechnolgy NAUT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$353K Sell
188,730
-1,084,653
-85% -$2.86M ﹤0.01% 5023
2026
Q1
$4.94M Buy
1,273,383
+253,387
+25% +$623K ﹤0.01% 2960
2025
Q4
$1.99M Buy
1,019,996
+52,448
+5% +$86K ﹤0.01% 3959
2025
Q3
$817K Sell
967,548
-89,291
-8% -$65.6K ﹤0.01% 4769
2025
Q2
$766K Buy
1,056,839
+967,224
+1,079% +$727K ﹤0.01% 4612
2025
Q1
$77.2K Buy
89,615
+51,911
+138% +$77.2K ﹤0.01% 5477
2024
Q4
$63.3K Buy
+37,704
New +$90.2K ﹤0.01% 5556
2024
Q2
Sell
-20,637
Closed -$60.7K 6316
2024
Q1
$60.7K Buy
20,637
+9,461
+85% +$26.8K ﹤0.01% 5662
2023
Q4
$33.4K Buy
+11,176
New +$32K ﹤0.01% 5547
2022
Q3
Sell
-112,784
Closed -$303K 7351
2022
Q2
$303K Sell
112,784
-230,577
-67% -$858K ﹤0.01% 5349
2022
Q1
$1.49M Buy
343,361
+253,804
+283% +$1.04M ﹤0.01% 4134
2021
Q4
$464K Sell
89,557
-198,092
-69% -$1.06M ﹤0.01% 5120
2021
Q3
$1.77M Buy
287,649
+249,548
+655% +$1.99M ﹤0.01% 4068
2021
Q2
$385K Buy
38,101
+17,760
+87% +$192K ﹤0.01% 5515
2021
Q1
$280K Sell
20,341
-196,677
-91% -$2.73M ﹤0.01% 5264
2020
Q4
$2.35M Buy
217,018
+60
+0% +$632 ﹤0.01% 3112
2020
Q3
$2.35K Buy
+216,958
New +$2.31M ﹤0.01% 2479

Other funds holding NAUT

Israel Englander's NAUT Position: Q2 2026 in Review

Israel Englander reduced its Nautilus Biotechnolgy (NAUT) stake by 85% in Q2 2026, selling an estimated $2.86M and leaving 188,730 shares worth $353K. The position accounts for ﹤0.01% of the portfolio, ranked #5023.

Israel Englander first reported a position in NAUT in Q3 2020 and has held it in 17 quarters since. The position peaked at $4.94M in Q1 2026. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

  • Israel Englander held 188,730 shares of Nautilus Biotechnolgy worth $353K as of Q2 2026.
  • Israel Englander sold 1,084,653 Nautilus Biotechnolgy shares in Q2 2026, an estimated $2.86M.
  • Nautilus Biotechnolgy made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #5023 holding.
  • Israel Englander first reported a position in Nautilus Biotechnolgy in Q3 2020 and has held it in 17 quarters since.
  • Israel Englander's Nautilus Biotechnolgy position peaked at $4.94M in Q1 2026.
  • 93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.